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Abstract
Background. To test the hypothesis that 5 mg/mL tramadol is superior to 3 mg/mL fentanyl when combined with 0.125%
ropivacaine in parturients undergoing labor during epidural analgesia.
Methods. Sixty-one parturients undergoing labor selected for delivery with epidural analgesia were randomized into two groups:
Group tramadol (0.125% ropivacaine plus tramadol 5 mg/mL) and Group fentanyl (0.125% ropivacaine plus fentanyl 3 mg/
mL). Hemodynamics, rate of cesarean delivery, sensory block level, Bromage motor scale scores, instrument-assisted delivery,
oxytocin use, visual analog scale (VAS) scores, Apgar scores, umbilical cord artery gas analysis, and maternal side-
effects including nausea, vomiting, pruritus, urinary retention, shivering, hypotension, and respiratory depression were
recorded.
Results. The two groups had no signiﬁcant differences with respect to maternal hemodynamics, neonatal heart rate, VAS scores,
rate of cesarean delivery, sensory block level, Bromage motor scale scores, instrument-assisted delivery, oxytocin use,
hypotension, nausea, vomiting, and respiratory depression (p > 0.05). The incidence of pruritus, shivering, and urinary
retention were more commonly observed in Group fentanyl despite there was no signiﬁcant difference between the two groups.
Umbilical artery pH was signiﬁcantly lower while PCO2 was higher in Group fentanyl than Group tramadol (p = 0.003 and
p = 0.026, respectively). Birth-weight, umbilical artery PO2 and base deﬁcit, and Apgar scores at 1 and 5 min were comparable
between the two groups (p > 0.05).
Conclusions. Our observations suggest that tramadol seems to be a safe alternative to fentanyl for labor analgesia due to its
similar analgesic efﬁcacy.
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Introduction
Epidural nerve block is widely used for labor analgesia
because of its effective pain relief, reduced maternal
stress response, improved parturient satisfaction, and
potential ability to provide anesthesia (1). The quality
of analgesiais improved with the combined use of a
local anesthetic and an opioid when combined with
theuseofeitheragentalone.Anexampleofacombina-
tion epidural therapy that provides excellent sensory
block with relatively little motor block includes a
co-administration of ropivacaine and fentanyl (2).
However,theside-effectsoffentanylarestillofconcern
during its use in perioperative period (3).
Tramadol not only binds to opioid m-receptors but
also interacts with the central nervous system by
inhibiting the withdrawal of noradrenaline and sero-
tonin (4). The unique pharmacological proﬁle of
tramadol makes it an attractive drug for postoperative
pain management. In several preliminary clinical
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effective drug for epidural analgesia (5,6).
Hence, the purpose of the present study was to
compare the analgesic and side-effects of two solu-
tions that combined 0.125% ropivacaine with either
tramadol 5 mg/mL or fentanyl 3 mg/mL in parturients
undergoing labor during epidural analgesia.
Materials and methods
The Human Investigations Committee of Jintan
Hospital approved the present study protocol, and
prior written informed consents were obtained from
all parturients. A total of 66 nulliparous parturients,
with ASA class I or II, eligible for labor epidural
analgesia were sequentially enrolled from May 2008
to June 2009 in this prospective, randomized, double-
blinded study. Parturients with multiple pregnancies,
a history of previous local anesthetic events, hyper-
tension in pregnancy with proteinuria, cardiac dis-
eases, any other major medical disorder associated
with pregnancy , and contraindications for epidural
analgesia were excluded.
Based on a computer-generated grouping number
sheet, the patients were randomized into two groups:
Group tramadol (n = 33) and Group fentanyl (n = 33).
The mixed solutions for epidural analgesia were pre-
pared under sterile conditions by an anesthetist and
administered by a second anesthetist who remained
blinded to the solution prescription. Each parturient
received 250 mL lactated Ringer’s solution over 20–
30minbeforeepiduralinjectionandwaskeptintheleft
lateral position for epidural puncture when cervical
dilation was ‡2 cm. The epidural puncture was per-
formedattheL2–3interspacewithamid-lineapproach
and 3 cm of the catheter was placed cephalicly to the
left in the epidural space. Aspiration of the in-
place catheter for blood or cerebrospinal ﬂuid was
done to rule out incorrect placement. Five minutes
later,ifsensoryblocklevelwasobtained,aloadingdose
wasadded.Grouptramadolreceived10mLof0.125%
ropivacaine (AstraZeneca, Södertälje, Sweden) plus
5 mg/mL tramadol (Grunenthal GmbH, Germany),
and Group fentanyl received 10 mL of 0.125% ropi-
vacaine plus 3 mg/mL fentanyl (50 mg/mL; Renfu Co.,
Hubei, China). The aforementioned two solutions
were also used for subsequent analgesia maintenance
at a constant infusion rate of 6 mL/h until full dilation
of the cervix was achieved. If pain relief was not
satisfactory 15 min after continuous infusion, parturi-
ents could receive a supplemental dose of 5 mL bolus
via the epidural catheter. Subject pain was assessed
witha10-cmlinearvisualanaloguescale(VAS),where
0 represented ‘no pain’ and 10 represented ‘most
severe pain’. Pain scores were determined just before
epidural placement and 5, 10, 15, 20, 25, 30, 60 min
after epidural injection. Motor block was assessed
by means of a modiﬁed four-grade Bromage scale
(0 = able to lift extended leg at hip; 1 = able to ﬂex
knee but not lift extended leg; 2 = able to move foot
only; and 3 = unable to move foot) (7).Each parturient
received a 5 mL of 1% lidocaine as the testing and
initial dose.
The following data were collected as demographic
characteristics of the subjects: age at delivery, height,
weight, and gestational age. Intraoperative hemody-
namics including mean blood pressure (MAP) and
heart rate (HR) at 5 min-intervals and pulse oxygen
saturation were continuously monitored. Additional
epidural analgesia agent requirements, instrument-
assisted delivery, oxytocin use, and cesarean delivery
were also recorded. Neonatal outcomes included fetal
heart rate monitoring via a Doppler device, birth-
weight, Apgar scores, and umbilical cord blood gas
analysis. Immediately after delivery, with the placenta
in situ and ideally prior to the neonate’s ﬁrst breath, an
umbilical cord segment was isolated utilizing cord
clamps. Umbilical arterial blood samples were col-
lected using a 1 mL pre-heparinizedplastic syringe
(Rapidlyte
 ; Bayer Corporation, EastWalpole, MA,
USA) and a 21-gauge needle. Analysis was performed
immediately after collection using a blood gas ana-
lyzer (GEM Premier 3000, Guangzhou, China).
Maternal respiratory depression was deﬁned as
oxygen saturation below 95%. Other side-effects
including nausea, vomiting, shivering, hypotension,
vomiting, pruritus,and urinary retention were also
recorded.
Statistical analysis
Sample size calculation was performed according to
a previously published study (8);29 parturients per
group would have 80% power at the 5% signiﬁcance
level to detect a difference in umbilical arterial pH of
0.03 with standard deviation (SD) 0.04 for indepen-
dent t test between the two groups. To allow for a
possible drop-out rate of 10%–15%, a total of 66 par-
turients were enrolled in the present study. Values are
expressed as number, mean and standard deviation
(mean ± SD), or median (range). Student’s unpaired t
tests were used for continuous variables, and chi-
square tests were used for categorical variables.
Inter-group comparisons of maternal HR, MAP,
and VAS scores and neonatal HR at the same time
were tested using analysis of covariance. p < 0.05 was
regarded as statistically signiﬁcant. Statistical analysis
was performed with the use of SPPS 16.0 for windows
(SPSS Inc., Chicago, IL, USA).
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Demographic data
Successful epidural block was achieved in 32 parturi-
ents in Group tramadol and 33 in Group fentanyl.
Two parturients in Group tramadol and two parturi-
ents in Group fentanyl underwent cesarean delivery
later. Therefore 30 parturients in Group tramadol
and 31 parturients in Group fentanyl completed the
present study. The two groups of parturients were
compared with regard to maternal age, weight at term,
height, gestational age, VAS scores, and stage of
cervical dilation at base-line. Demographic variables
and obstetric characteristics were similar between the
two groups. Base-line VAS pain scores, cervical dila-
tion, and fetal heart rate were also similar between the
two groups (Table I and Figure 1).
Maternal data
Maternal hemodynamic data are shown in Figure 1
and dermatomal sensory levels are presented in Table
II. There was no signiﬁcant difference in maternal
MAP, HR, and VAS scores and neonatal HR between
the two groups at any time points (p > 0.05). Further-
more, no parturients required additional epidural anal-
gesia agent. Moreover, no signiﬁcant difference was
observed between the two groups in the percentages
of subjects who were treated with oxytocin (p = 0.228).
There was also no statistical signiﬁcance in the rate of
instrument-assisted delivery and rate of cesarean deliv-
ery between the two groups (p = 0.996 and p = 0.973,
respectively).
Side-effects
Although no signiﬁcant difference was seen, there was a
tendency that the incidence of side-effects (pruritus,
shivering, and urinary retention) was higher in Group
fentanyl. No signiﬁcantdifferencewas observedin other
side-effects such as nausea, vomiting, motor block,
respiratory depression, and hypotension between the
two groups (Table II). Furthermore, none of the par-
turients in any group required speciﬁc treatment during
labor.
Neonatal data
Neonatal data are presented in Table III. Birth-weight,
umbilical arterial blood oxygen partial pressure and
base deﬁcit,lactateconcentrations,andApgarscoresat
1 and 5 min were comparable between the two groups.
Umbilical arterial blood pH was signiﬁcantly lower,
while arterial blood carbon dioxide partial pressure was
higher inthe fentanyl group than in the tramadol group
(p = 0.001 and p = 0.026, respectively).
Discussion
In this prospective, randomized, double-blinded
study, we found that tramadol is as safe an adjunct
as fentanyl to ropivacaine for pain management in
labor epidural analgesia.
Pain management is essential for good obstetrical
care, and effective analgesia is beneﬁcial for both
maternal and neonatal health (1). Epidural block is an
attractive method for laboring analgesia. The epidural
addition of opioid to local anesthetics has become a well
accepted practice in the management of labor anal-
gesia, since this modality can provide reasonable pain
relief while decreasing the total dose of each agent, thus
minimizing the relative side-effects. Fentanyl is a widely
usedopioidinclinicalpractice.However,thesigniﬁcant
side-effects including pruritus, urinary retention, severe
nausea and vomiting, and, occasionally, respiratory
depression, are still unsettled (9). On the other hand,
epidural administration of tramadol has not been well
studied especially in labor analgesia. The analgesia
effects of tramadol are mainly attributed to its dual
mechanismofactionaspreviouslydescribed(4).Added
tothis,itslocalanestheticactionmaybeanotherpossible
mechanism responsible for its analgesia effects (10).
Importantly, it provided effective analgesia without
Table I. Demographic data in each group.
Group tramadol (n = 30) Group fentanyl (n = 31)
Age (years) 26.0 ± 3.1 25.3 ± 2.6
Weight (kg) 69 ± 66 8 ± 7
Height (cm) 161 ± 5 160 ± 5
Gestational age (weeks) 39.2 ± 1.2 39.5 ± 1.3
Cervical dilatation (cm): start of study 3.5 ± 1.0 3.4 ± 0.9
Values are expressed as mean ± SD. There was no difference between the two groups.
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Figure 1. Changes in maternal HR, MAP, VAS scores, and fetal HR in each group. Values are expressed as mean ± SD. There was no
signiﬁcant difference between the two groups at any time points (p > 0.05).
Table II. Maternal data in each group.
Group tramadol (n = 30) Group fentanyl(n = 31) P value
Nausea (n) 2 3 0.671
Vomiting (n) 0 1 0.508
Pruritus (n) 0 4 0.081
Shivering (n) 0 3 0.238
Urinary retention (n) 0 2 0.492
Respiratory depression (n)0 0 –
Oxytocin use (n) 9 11 0.228
Instrument assisted delivery (n) 3 3 0.996
Cesarean delivery (n) 2 2 0.973
Additional requirements for
epidural analgesic agent (n)
00 –
Hypotension (n)0 0 –
Duration of ﬁrst stage (min) 471 ± 143 451 ± 134 0.567
Duration of second stage (min) 50 ± 15 52 ± 16 0.480
Onset of sensory block (min) 4.4 ± 0.6 4.6 ± 0.6 0.181
Highest sensory block T9 (T6–T10) T8 (T6–T9) 0.353
Motor block:
Maximum Bromage scale (n)
0-1-2-3 (n)
24-6-0-0 23-8-0-0 0.590
Values are expressed as number, mean ± SD, or median (range). There was no difference between the two groups.
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side-effects (5). The pharmacological proﬁles of trama-
dol along with minimal side-effects make it an attractive
drug for epidural administration.
In the present study, comparative VAS scores
obtained in both groups suggested that tramadol was
as effective as fentanyl for labor epidural analgesia.
Moreover, we could not ﬁndany difference in the onset
timeofsensoryblockbetweenthetwogroups.However,
prolongation of pain recognition after the epidural
administration of tramadol in human study has been
reported previously (11). Our own preliminary studies
also demonstrated that the onset time of anesthesia of
tramadol was longer than fentanyl. Here, we used lido-
caine as the testing dose (1% and 5 mL solution), a
routine dosage regime at our institution, to make up for
the slow onset time of sensory block of tramadol. Fur-
thermore, the intensity of motor block, as reﬂected by
Bromagemotorscalescores,wassimilarbetweenthetwo
groups. These results were also supported by previous
studies (12), in which they showed that ropivacaine
0.125% produced a low incidence of motor block.
With regard to the side-effects, there was a ten-
dency that the incidence of shivering was higher in
parturients who received fentanyl, a mechanism that
might be mediated by its serotonergic or noradren-
ergic activity (13). Shivering causes distress and
increased oxygen consumption to the parturients
and thus may induce arterial hypoxemia. Moreover,
pruritus and urinary retention seemed to be higher in
Group fentanyl, although no signiﬁcant difference
was seen between the two groups. As the present
study is a pilot study, more studies with larger sample
sizes are suggested to test these observations.
Epiduraluseoffentanylmayreintroducetheproblem
of neonatal depression just as when it was used
intravenously (14). Though the Apgar scoring system
is a valuable surrogate for assessment of neonatal
well-being immediately after birth (15), a growing
body of evidence suggests that umbilical arterial pH
may provide objective documentation to assess intra-
partum care (16). More recently, White et al. (17) even
showed that introduction of universal umbilical cord
blood gas analysis may result in improved perinatal
outcomes.Theresultsofthepresentstudydemonstrated
that Apgar scoresat 1 and 5 min in allthe neonateswere
morethan7.However,weobservedthatfentanylusewas
associated with a higher PaCO2 and a lower umbilical
cord blood pH values than tramadol use.
There are three obvious limitations in the present
study. First, pH is an objective retrospective mea-
sure of the fetal exposure and response to hypoxia
during labor. The timing of cord blood clamping
therefore seems to be critical for the interpreta-
tion of cord blood gases that may be involved in
the processes and procedures. But this bias was
unlikely because the procedure was performed by
the same midwife. Second, the analgesic potency
ratio between epidural administration of tramadol
and fentanyl remains unclear. Previous study has
suggested that the analgesic potency ratio of fentanyl
and tramadol is nearly 1:1000 after intramuscular
injection (18). Our own preliminary study showed
that fentanyl 5 mg/mL is associated with more side-
effects and tramadol 5 mg/mL had similar analgesic
efﬁcacy to fentanyl 3 mg/mL. Therefore, we chose
the ﬁnal doses of tramadol 5 mg/mL and fentanyl
3 mg/mL in the present study. Third, although epi-
dural administration of tramadol has been exten-
sively used for analgesia by numerous investigators
in clinical studies, more studies are needed to assess
the safety for its neurotoxicity.
Table III. Neonatal data in each group.
Group tramadol (n = 30) Group fentanyl(n = 31) P value
Birth-weight (kg) 3.4 ± 0.4 3.5 ± 0.4 0.465
Apgar scores
1 min 9 (7–10) 9 (7–10) 0.608
5 min 10 (8–10) 10 (8–10) 0.751
Umbilical arterial blood acid–base status
pH 7.27 ± 0.04 7.23 ± 0.04 0.001
PO2 (mmHg) 15.2 ± 4.2 15.0 ± 4.5 0.859
PCO2 (mmHg) 52 ± 65 7 ± 10 0.026
Base excess (mmol/L) -3.0 ± 2.7 -3.9 ± 2.9 0.232
Lactate concentrations (mmol/L) 4.1 ± 1.1 4.3 ± 1.3 0.549
Values are expressedas mean ± SD or median (range). Umbilical arterialpH was signiﬁcantlylower, while PaCO2 was higherin Group fentanyl
than Group tramadol.
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had similar analgesia efﬁcacy to fentanyl 3 mg/mL with
fewer maternal and neonatal side-effects, suggesting
that tramadol may be a safe alternative to fentanyl as
an adjunct for labor analgesia.
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